G. Funke et al., MOST CORYNEBACTERIUM-XEROSIS STRAINS IDENTIFIED IN THE ROUTINE CLINICAL LABORATORY CORRESPOND TO CORYNEBACTERIUM-AMYCOLATUM, Journal of clinical microbiology, 34(5), 1996, pp. 1124-1128
A comprehensive study was performed on 25 bacterial clinical isolates
originally identified as Corynebacterium xerosis. Three reference stra
ins of C. xerosis were also included in the study, On the basis of a v
ariety of phenotypic characteristics tested, all strains could be divi
ded into two separate clusters: reference strains ATCC 373 (the type s
train of C. xerosis) and ATCC 7711 showed yellow-pigmented, dry, rough
colonies, fermented 5-keto-gluconate, exhibited strong leucine arylam
idase and alpha-glucosidase activities, produced lactate as the major
end product of glucose metabolism, were susceptible to most of the 19
antimicrobial agents tested, and showed an inhibition zone around disk
s containing the vibriocidal compound O/129. In contrast, the remainin
g 26 strains including reference strain NCTC 7243 as well as all clini
cal isolates formed white-grayish, dry, slightly rough colonies, did n
ot ferment 5-keto-gluconate, exhibited only weak leucine arylamidase a
nd no cy-glucosidase activity, produced large amounts of propionic aci
d as the end product of glucose metabolism, and were resistant to most
antimicrobial agents tested, including O/129. Chemotaxonomic (cellula
r fatty acids, mycolic acids, and G+C content) and molecular genetic (
16S rRNA gene sequence) investigations revealed that the strains of th
e second cluster unambiguously belonged to the species C. amycolatum.
Our data suggest that most strains reported in the literature as C. xe
rosis are probably misidentified and correspond to C. amycolatum.